Delayed reversible posterior encephalopathy syndrome following chemotherapy with oxaliplatin

Clinical Colorectal Cancer

Volumn 8, Issue 3, 2009, Pages 163-165

  Sharief, Ubaidullah ^a   Perry, David J ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

5 Fluorouracil; Colon carcinoma; Leucovorin; Leukoencephalopathy; Seizure

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PROPOFOL;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; CLINICAL FEATURE; COLON CARCINOMA; DIFFUSION WEIGHTED IMAGING; EPILEPTIC STATE; FEMALE; HUMAN; MALE; PARIETAL LOBE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; SEIZURE;

EID: 69549111606     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2009.n.026     Document Type: Article

References (23)

1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior Leukoencephalopathy syndrome. N Engl J Med 1996; 334:494-500.
2. Lee VH, Eelco MD, Wijdicks FM. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008; 65:205-210 (Pubitemid 351240781)
3. Kozak OS, Wijdicks EF, Manno EM, et al. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 2007; 69:894-897 (Pubitemid 47329589)
4. Hauser RA, Lacey DM. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol 1988; 45:1078-1083 (Pubitemid 18239192)
5. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002; 23:1038-1048
6. Appignani BA, Bhadelia RA, Blacklow SC, et al. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol 1996; 166:683-688
7. Small SL, Fukui MB, Bramblett GT, et al. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol 1996; 40:575-580
8. Truwit CL, Denaro CP, Lake JR, et al. MR imaging of reversible cyclosporin Ainduced neurotoxicity. AJNR Am J Neuroradiol 1991; 12:651-659
9. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000; 69:467-472 (Pubitemid 30129574)
10. Kou R, Greif D, Michel T. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem 2002; 277:29669-29673 Epub 2002 Jun 5.
11. Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998; 1366:211-223
12. Serkova NJ, Christians U, Benet LZ. Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 2004; 4:97-107.
13. Ito Y, Arahata Y, Goto Y, et al. Cisplatin Neurotoxicity presenting as Reversible Posterior Leukoencephalopathy Syndrome. AJNR Am J Neuroradiol 2008; 19:415-417
14. Vieillot S, Pouessel D, de Champfleur NM, et al. Reversible posterior Leukoencephalopathy syndrome after carboplatin therapy. Ann Oncol 2007; 18:608-609 (Pubitemid 46359652)
15. Ozcan C, Wong SJ, Hari P. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006; 354:980. (Pubitemid 43313688)
16. Tam CS, Galanos J, Seymour JF, et al. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol 2004; 77:72. (Pubitemid 39108801)
17. Schwaighofer BW, Hesselink JR, Healy ME. MR demonstration of reversible brain abnormalities in eclampsia. J Comput Assist Tomogr 1989; 13:310-312 (Pubitemid 19085178)
18. Lamy C, Oppenheim C, Meder JF, et al. Neuroimaging in Posterior Reversible Encephalopathy Syndrome. J Neuroimaging 2004; 14:89-96. (Pubitemid 38391815)
19. Weingarten K, Barbut D, Filippi C, et al. Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging. AJR Am J Roentgenol 1994; 162:665-670 (Pubitemid 24093575)
20. Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 2005; 35:83-90. (Pubitemid 40343439)
21. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999; 246:339-346
22. Skelton MR, Goldberg RM, O'Neil BH. A case of oxaliplatin-related posterior reversible encephalopathy syndrome. Clin Colorectal Cancer 2007; 6:386-388 (Pubitemid 46340206)
23. Pinedo DM, Shah-Khan F, Shah PC. Reversible Posterior Leukoencephalopathy Syndrome Associated With Oxaliplatin. J Clin Oncol 2007; 25:5320-5321 (Pubitemid 350232266)